Introducing Bluefish Pharmaceuticals AB New CEO


On behalf of Bluefish Pharmaceuticals AB’s Board of Directors, we are very pleased to announce that we have chosen Berit Lindholm to serve as the next Chief Executive Officer.

Berit joined Bluefish in 2015 in a position as COO and is a natural choice to take over when Karl Karlsson has now decided to pursue new opportunities outside Bluefish. Berit has extensive experience within the Pharmaceutical Industry before joining Bluefish Pharmaceuticals.

Karl will continue to support Bluefish long term strategy as an active board member.


Gerald Engström, Main owner and Chairman of the Board of Directors

Ph: +46 70 519 00 01

Erika Kjellberg Eriksson, Main owner and Member of the Board of Directors

Ph: +46 76 117 18 23

About Us

Bluefish has undergone significant international expansion since the company was founded in 2005. Bluefish focuses on the development, manufacture and sale of generic pharmaceuticals. The company conducts marketing operations in a large number of European markets and is expanding into territories outside Europe. The product portfolio consists of a total of 80 products and is growing. The company is owned by its founder Karl Karlsson, together with a number of investment funds and private investors.